Press Releases

Newsroom
In the News
Press Releases
Resources for Journalists

Press Releases

Share
Share
and/or
509 News Releases found
Pictured: José Baselga
Memorial Sloan Kettering Cancer Center Announces Appointment of New Physician-in-Chief

Internationally recognized physician-scientist José Baselga has been named Physician-in-Chief of Memorial Hospital. He joins Memorial Sloan Kettering from Massachusetts General Hospital.
Childhood Cancer Treatment Found to Pose Similar Risk for Breast Cancer as BRCA Mutations

New data reveals that women treated with radiation to the chest for childhood cancer have a high risk of developing breast cancer similar to that of women with <i>BRCA1/2</i> mutations. The study, led by Memorial Sloan Kettering Cancer Center biostatistician Chaya Moskowitz, PhD, was presented today at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.
Testing for Mutations Identified in Squamous Cell Lung Cancer Tumors Helps Personalize Treatment

Researchers from Memorial Sloan Kettering Cancer Center have begun testing for three new genetic targets and found that together they occur in approximately 50 percent of patients with squamous cell carcinomas of the lung, which affects 40,000 Americans each year. Initial findings of the research will be presented on June 4 at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.
Memorial Sloan Kettering Commack Offers Free Mammograms to Eligible Women on Long Island

Women on Long Island who don’t have insurance or who are underinsured may be able to take advantage of free mammograms at Memorial Sloan Kettering Cancer Center Commack.
Pictured: The Webby Awards
Memorial Sloan Kettering's Website Nominated for Webby Award

Memorial Sloan Kettering Cancer Center’s website has been nominated for The Webby Award, the most prestigious international award honoring excellence on the Internet. Selected from among nearly 10,000 total entries, the Center’s website is one of five nominated in the Health category.
Media Advisory
Antibody Therapy Prevents Gastrointestinal Damage following Radiation Exposure in Mice

A new study offers the first evidence of a drug capable of preventing lethal damage to the gastrointestinal (GI) tract caused by exposure to high levels of ionizing radiation, such as those occurring during a nuclear incident.
Memorial Sloan Kettering Cancer Center, IBM to Collaborate in Applying Watson Technology to Help Oncologists

Memorial Sloan Kettering and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson to provide medical professionals with improved access to comprehensive cancer data and practices.
Genetic Profiling Can Help Doctors More Accurately Predict Prognosis and Guide Treatment Decisions for Leukemia Patients

Researchers have identified a set of genetic abnormalities in patients with acute myelogenous leukemia (AML) that doctors can use to more accurately predict patients’ prognoses and select treatments that are most likely to benefit them. The study, led by investigators at Memorial Sloan Kettering Cancer Center, will be published in the March 22 issue of the <i>New England Journal of Medicine</i>.
Rare Medical Phenomenon Of Systemic Tumor Disappearance Following Local Radiation Treatment Reported In A Patient With Metastatic Melanoma

A rarely seen phenomenon in cancer patients — in which focused radiation to the site of one tumor is associated with the disappearance of metastatic tumors all over the body — has been reported in a patient with melanoma treated with the immunotherapeutic agent ipilimumab (Yervoy™).
Colonoscopy Prevents Deaths From Colon Cancer

For the first time, a new study has shown that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease. Patients in the study were evaluated for up to 23 years after having the procedure, providing the longest follow-up results to date.